Publications

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. Rationale and Design of the Hot-Pe Trial (Vol 116, Pg 191, 2016)

AuthID
P-00M-4T8

Author(s)

Barco, S

Lankeit, M

Binder, H

Schellong, S

Christ, M

Beyer Westendorf, J

Duerschmied, D

Bauersachs, R

Empen, K

Held, M

Schwaiblmair, M

Fonseca, C

Jimenez, D

Becattini, C

Quitzau, K

Espinola Klein, C

Wild, P

Konstantinides, S

Document Type

Correction

Year published

2016

Published

in THROMBOSIS AND HAEMOSTASIS, ISSN: 0340-6245

Volume: 116, Issue: 4, Pages: 775-775 (1)

Indexing

Wos^®

Google Scholar^®

Publication Identifiers

DOI: 10.1160/th16100001

Wos: WOS:000384964200026

Source Identifiers

ISSN: 0340-6245

Export Publication Metadata

Marked List

Add to Marked List

Citations

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference

No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info

At this moment we don't have any links to full text documens.

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. Rationale and Design of the Hot-Pe Trial (Vol 116, Pg 191, 2016)

Useful Links

Get Help

Federated Authentication (Click on the image)

Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban. Rationale and Design of the Hot-Pe Trial (Vol 116, Pg 191, 2016)

Useful Links

Get Help